JP5519639B2 - 秩序化したメソポーラスシリカ材料 - Google Patents

秩序化したメソポーラスシリカ材料 Download PDF

Info

Publication number
JP5519639B2
JP5519639B2 JP2011506686A JP2011506686A JP5519639B2 JP 5519639 B2 JP5519639 B2 JP 5519639B2 JP 2011506686 A JP2011506686 A JP 2011506686A JP 2011506686 A JP2011506686 A JP 2011506686A JP 5519639 B2 JP5519639 B2 JP 5519639B2
Authority
JP
Japan
Prior art keywords
pore size
range
cok
ordered mesoporous
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011506686A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518756A5 (enExample
JP2011518756A (ja
Inventor
ジャンマー，ジャスパー
アールツ，アレクサンダー
デン ムーター，ガイ ヴァン
マルテンス，ヨハン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Formac Pharmaceuticals NV
Original Assignee
Formac Pharmaceuticals NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0807696A external-priority patent/GB0807696D0/en
Priority claimed from GB0903395A external-priority patent/GB0903395D0/en
Application filed by Formac Pharmaceuticals NV filed Critical Formac Pharmaceuticals NV
Publication of JP2011518756A publication Critical patent/JP2011518756A/ja
Publication of JP2011518756A5 publication Critical patent/JP2011518756A5/ja
Application granted granted Critical
Publication of JP5519639B2 publication Critical patent/JP5519639B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B37/00—Compounds having molecular sieve properties but not having base-exchange properties
    • C01B37/02—Crystalline silica-polymorphs, e.g. silicalites dealuminated aluminosilicate zeolites
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/249921—Web or sheet containing structurally defined element or component
    • Y10T428/249953—Composite having voids in a component [e.g., porous, cellular, etc.]
    • Y10T428/249978—Voids specified as micro
    • Y10T428/249979—Specified thickness of void-containing component [absolute or relative] or numerical cell dimension

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicon Compounds (AREA)
  • Steroid Compounds (AREA)
JP2011506686A 2008-04-28 2009-04-28 秩序化したメソポーラスシリカ材料 Expired - Fee Related JP5519639B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US12579508P 2008-04-28 2008-04-28
US61/125,795 2008-04-28
GB0807696A GB0807696D0 (en) 2008-04-28 2008-04-28 Ordered mesoporous silica material
GB0807696.0 2008-04-28
US13767308P 2008-08-01 2008-08-01
US61/137,673 2008-08-01
US20153208P 2008-12-11 2008-12-11
US61/201,532 2008-12-11
GB0903395A GB0903395D0 (en) 2009-02-27 2009-02-27 Ordered mesoporous silica material
GB0903395.2 2009-02-27
PCT/EP2009/055122 WO2009133100A2 (en) 2008-04-28 2009-04-28 Ordered mesoporous silica material

Publications (3)

Publication Number Publication Date
JP2011518756A JP2011518756A (ja) 2011-06-30
JP2011518756A5 JP2011518756A5 (enExample) 2014-04-17
JP5519639B2 true JP5519639B2 (ja) 2014-06-11

Family

ID=41059555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506686A Expired - Fee Related JP5519639B2 (ja) 2008-04-28 2009-04-28 秩序化したメソポーラスシリカ材料

Country Status (10)

Country Link
US (1) US20110081416A1 (enExample)
EP (1) EP2282973A2 (enExample)
JP (1) JP5519639B2 (enExample)
CN (1) CN102066256A (enExample)
AU (1) AU2009242175B2 (enExample)
BR (1) BRPI0910838A2 (enExample)
CA (1) CA2721485C (enExample)
MX (1) MX2010011670A (enExample)
WO (1) WO2009133100A2 (enExample)
ZA (1) ZA201007548B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130203602A1 (en) * 2010-03-11 2013-08-08 Danmarks Tekniske Universitet Supported biologically active compounds
CN101823001B (zh) * 2010-04-29 2012-08-01 上海师范大学 氨基桥联有序介孔有机碱非均相催化剂的制备方法
WO2012025624A1 (en) 2010-08-27 2012-03-01 Formac Pharmaceuticals N.V. Processes for producing microporous silica materials
WO2012035074A1 (en) * 2010-09-14 2012-03-22 Nanologica Ab Super-saturating delivery vehicles for poorly water-soluble pharmaceutical and cosmetic active ingredients
US20130243833A1 (en) 2010-11-29 2013-09-19 Formac Pharmaceuticals N.V. Compressed formulations of ordered mesoporous silicas
EP2811829B1 (en) * 2012-01-23 2018-11-14 Syngenta Limited Process for enhancing plant growth
JP5652792B2 (ja) * 2012-04-27 2015-01-14 株式会社クラレ メソポーラスシリカの製造方法
CN113842362A (zh) 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
WO2014148230A1 (ja) * 2013-03-19 2014-09-25 株式会社クラレ コーティング組成物及びそれを用いるメソポーラスシリカの製造方法
JP2017511331A (ja) * 2014-03-31 2017-04-20 ノバルティス ファーマ アーゲー 薬学的活性種を含む化合物を含有する多孔質材料
WO2016041992A1 (en) 2014-09-15 2016-03-24 Grace Gmbh & Co. Kg Active-loaded particulate materials for topical administration
KR102695606B1 (ko) 2016-02-02 2024-08-14 유니버시티 오브 워싱턴 세라믹 선택적 막
AU2019205299B2 (en) 2018-01-04 2024-02-22 University Of Washington Nanoporous selective sol-gel ceramic membranes, selective -membrane structures, and related methods
EP3517500A1 (en) 2018-01-24 2019-07-31 Technische Universität Berlin A method for obtaining mesoporous silica particles with surface functionalisation
US12459829B2 (en) 2018-11-07 2025-11-04 Disruptive Pharma Ab Amorphous active pharmaceutical ingredients comprising substantially amorphous mesoporous magnesium carbonate
WO2020234675A1 (en) * 2019-04-30 2020-11-26 Vialpando, Llc Amorphous cannabinoid composition and processes of manufacture
WO2020222029A1 (en) * 2019-04-30 2020-11-05 Vialpando, Llc Cannabinoid composition and processes of manufacture
CN111743685B (zh) * 2020-06-24 2022-07-15 天晴干细胞股份有限公司 一种医用冷敷贴
FR3122585A1 (fr) 2021-05-04 2022-11-11 Universite Claude Bernard Lyon 1 Solide mésoporeux pour réguler l’humidité dans les espaces clos
CN114920252A (zh) * 2022-06-28 2022-08-19 辽宁方诺生物科技有限公司 一类手性介孔二氧化硅纳米粒及其制备和应用
CN114988415B (zh) * 2022-07-01 2023-07-28 东北大学 一种硼酸辅助后处理制备介孔二氧化硅纳米粒子的方法
CN118270794B (zh) * 2024-04-22 2025-03-04 复旦大学 一种非晶二氧化硅二维材料及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607705B2 (en) * 2000-04-13 2003-08-19 Board Of Trustees Of Michigan State University Process for the preparation of molecular sieve silicas
WO2003037511A1 (en) * 2001-11-01 2003-05-08 Silicycle Inc. Method of preparing highly ordered mesoporous molecular sieves
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
CN1247455C (zh) * 2002-12-30 2006-03-29 新加坡纳米材料科技有限公司 一种二氧化硅介孔材料及其制备方法
ES2247921B1 (es) * 2004-04-07 2007-06-16 Universidad Politecnica De Valencia Un material amorfo microporoso, procedimiento de preparacion y su uso en la conversion catalitica de compuestos organicos.
CN1268545C (zh) * 2004-06-24 2006-08-09 华东理工大学 可用于纳米标准颗粒的纳米二氧化硅的制备方法
GB0420016D0 (en) * 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system

Also Published As

Publication number Publication date
WO2009133100A3 (en) 2009-12-23
EP2282973A2 (en) 2011-02-16
AU2009242175B2 (en) 2013-02-07
ZA201007548B (en) 2011-07-27
WO2009133100A2 (en) 2009-11-05
MX2010011670A (es) 2011-05-02
AU2009242175A1 (en) 2009-11-05
CA2721485C (en) 2013-12-24
CN102066256A (zh) 2011-05-18
JP2011518756A (ja) 2011-06-30
BRPI0910838A2 (pt) 2017-05-30
CA2721485A1 (en) 2009-11-05
US20110081416A1 (en) 2011-04-07

Similar Documents

Publication Publication Date Title
JP5519639B2 (ja) 秩序化したメソポーラスシリカ材料
Vilaça et al. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma
US7563451B2 (en) Capped mesoporous silicates
Juère et al. On the nanopore confinement of therapeutic drugs into mesoporous silica materials and its implications
KR20210069740A (ko) 무기성 코팅을 갖는 고형의 나노입자
Ambrogi et al. Amorphous carbamazepine stabilization by the mesoporous silicate SBA-15
JP5848326B2 (ja) ペクチン−アドリアマイシン共役体の凍結乾燥製剤および製造方法
CN119564881A (zh) 生理活性物质载体
Qiu et al. Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: preparation, sustained release, cellular uptake and pharmacokinetics
HK1210415A1 (en) Bioerodible silicon-based devices for delivery of therapeutic agents
Zhang et al. Three dimensional macroporous hydroxyapatite/chitosan foam-supported polymer micelles for enhanced oral delivery of poorly soluble drugs
JP2011225380A (ja) メソポーラスシリカ材料の製造方法
Letchmanan et al. Dissolution and physicochemical stability enhancement of artemisinin and mefloquine co-formulation via nano-confinement with mesoporous SBA-15
Jadhav et al. Mesoporous silica nanoparticles (MSN): a nanonetwork and hierarchical structure in drug delivery
Song et al. Multifunctional dual-mesoporous silica nanoparticles loaded with a protein and dual antitumor drugs as a targeted delivery system
Liu et al. Dual-generation dendritic mesoporous silica nanoparticles for co-delivery and kinetically sequential drug release
RU2476377C2 (ru) Упорядоченный мезопористый кремнийоксидный материал
Zhang et al. Double-nano silica xerogel contributes to establish nifedipine delivery system with superior delivery effect
Veloso et al. Amorphous drug stabilization using mesoporous materials
Kim et al. Amine-grafted SBA-15 for ophthalmic delivery of dexamethasone
WO2012025624A1 (en) Processes for producing microporous silica materials
ITMI20012749A1 (it) Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut
Parmar et al. Novel nano-technologies to enhance drug solubility, dissolution and bioavailability of poorly water-soluble drugs
Rajkumar et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of paliperidone using different hydrophilic carriers: in vitro-in vivo study
Mahajan Development of Mesoporous Silica Nanoparticles for Bioavailability Enhancement of Some Anti Hiv Drugs

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110824

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131210

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20140225

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140318

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140403

R150 Certificate of patent or registration of utility model

Ref document number: 5519639

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees